3 Questions For An IP Marketing Professional (Part II)
Having a diversified and considered approach to marketing is the best way to spotlight your practice’s unique market offerings.
3 Questions For A Law School Admissions Expert (Part II)
Both pragmatism and resilience are essential to success in legal practice.
Chrometa: Turning Time Into Billable Value For Modern Lawyers
Adoption of Chrometa represents more than a technological upgrade; it reflects a professional philosophy that values accuracy, transparency, and efficiency.
3 Questions For A Law School Admissions Expert (Part I)
The surge in law school applications promises to make the 2026 application cycle one of the most competitive ever.
Watch Your Words
A patent owner’s statements about the scope of its patents must always be considered carefully.
3 IP Lessons From The 2025 LF Dealmakers Forum
The LF Dealmakers Forum reminds us of the need to stay vigilant, knowledgeable about the rules of the game, and flexible enough to adapt to policy decisions.
Texas Holds A Litigation Funding Conference Flush In 2026
The current patent litigation funding market is a lot like a cup of coffee.
Introducing LexisNexis Protégé™ in Lex Machina®
Lex Machina harnesses generative AI capabilities to revolutionize the way legal professionals interact with data to improve bottom line for their business.
3 Questions For A Law Firm Marketing Professional (Part I)
The confidential nature of the work done by IP attorneys adds complexity to marketing their achievements.
3 (IP) Takeaways From The Lex Machina 2025 Litigation Damages Report
The report’s presentation of data shows that modern patent litigation remains a vibrant and challenging pursuit for both plaintiffs and defendants.
Exacting Nexus Standard
The introduction of Cologuard after FDA-approval in 2014 has been a gamechanger in colon cancer diagnosis.
3 Questions For Another Court Access Crusader (Part II)
There is no doubt in my mind that Free Law Project’s tools are a must-add to any aspiring federal court litigator’s toolbox.
Why Your Practice Is Burning Money And How You Can Do Better
Our expert panel explores common sources of profit leakage along with practical steps for improvement.
3 Questions For Another Court Access Crusader (Part I)
The RECAP Archive gets a major enhancement.
3 Takeaways From The Lex Machina 2025 Patent Report
Modern patent litigation remains a vibrant and challenging pursuit for both plaintiffs and defendants.
Patenting Privation (Part III): Empowering Revenge
Much like America's waistline, a dispute between Eli Lilly and a large compounder called Empower Pharmacy is expanding.
Into The Sun: Federal Circuit Provides Clarity On The Role Of Injunctions In Pharma Cases
An interesting scenario where the limited lifespan of a patent renders it less effective as a means of keeping out a competitive product from the market.
3 Questions For A Tech Entrepreneur Turned Chinese Patent Enforcer (Part II)
Thoughts from a tech leader who stands as Microsoft's formidable opponent in a landmark patent infringement case in China.